22 Aug 2016 07:00
Sinclair Pharma plc
Notice of Results
London, 22 August 2016 - Sinclair Pharma plc (AIM: SPH.L) ("Sinclair" or "the Group"), the international company operating in the fast growing global aesthetics market, will announce its results for the six month period covering 1 January 2016 to 30 June 2016 on Wednesday 21 September 2016.
As previously announced, fully audited 18 month final results for the period 1 July 2015 to 31 December 2016 will be published in March 2017.
A briefing for analysts will be held at 09.30 BST at the offices of FTI Consulting, 200 Aldersgate, Aldersgate Street, London, EC1A 4HD. A live audio webcast and slide presentation will also be available after the event at www.sinclairpharma.com.
-Ends-
For further information, please contact:
Sinclair Pharma plc Chris Spooner/Alan Olby
| Tel: +44 (0) 20 7467 6920 |
Peel Hunt LLP James Steel/Oliver Jackson
| Tel: +44 (0) 20 7418 8900 |
FTI Consulting Ben Atwell/Brett Pollard | Tel: +44 (0) 20 3727 1000 |
About Sinclair Pharma plc
Sinclair Pharma plc is an international company that operates in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments.
The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. The group has an established sales and marketing presence in the leading EU markets' and a rapidly growing International division concentrated on the Emerging Markets through long term multi-product, multi-country, sales, marketing and distribution deals with key strategic partners.